Guidance
Update information
August 2015: Recommendation 1.3.13 was amended to refer to the recommendation in the updated NICE guideline on diabetes (type 1 and type 2) in children and young people rather than in the previous guideline (CG15).
Minor changes since publication
August 2023: We removed the dose and brand names for desmopressin in recommendation 1.10.4.
ISBN: 978-1-4731-2855-2